//./ActionParams/@language -> $page_language ->
The Economic Times
English EditionEnglish Editionहिन्दीગુજરાતી
| 26 September, 2020, 04:29 PM IST | E-Paper
Search
+
    ENG
    • ENG - English
    • HIN - हिन्दी
    • GUJ - ગુજરાતી
    • MAR - मराठी
    • BEN - বাংলা 
    • KAN - ಕನ್ನಡ 
    • ORI - ଓଡିଆ
    • TEL - తెలుగు
    • TAM - தமிழ்

    Divi's Laboratories Ltd.

    OPEN TRADING A/C
    • NSE
    • BSE
    Last Updated on 25 Sep, 2020, 03:59 PM IST
    3060.75

    Today's Change

    40.30 (1.33%)

    Volume
    AVERAGE VOLUME
    5-Day
    10-Day
    30-Day

    1,595,002

    Open

    3060.00

    Prev. Close

    3020.45

    Day's Trend

    Low
    3004.65
    High
    3108.00
    • Bid
    • Mkt Cap (₹ Cr.)
    • P/E (x)
    • P/B (x)
    • Div_ Yield (%)
    • BETA
      BETA
      1 Month
      3-Months
      6-Months
      1 Year
      3-Years
    • Offer
    • Face Value (₹)2.00
    • EPS-TTM (Rs.)60.13
    • BV/share (₹)275.36
    • 52Wk L/H1595.05/ 3389.00
    • Avg. Daily Volatility %
      Avg. Daily Volatility %
      1 Month
      3-Months
      6-Months
      1 Year
      3-Years
    InsightsCandle Pattern| Events| Recos| Updates| News

    Divi's Laboratories Ltd Stock Price F & O Quotes

    Buy Divi's Lab, price target Rs 1865: CK Narayan| Recos
    Buy
    Buy Divi's Lab, price target Rs 1880: CK Narayan| Recos
    Buy
    Buy Divi's Lab, target price Rs 1,800: Swati Hotkar| Recos
    Buy
    Buy Divi's Laboratories, target Rs 1,725: Kunal Bothra| Recos
    Buy
    Buy Divi's Laboratories, target Rs 1,680: Kunal Bothra| Recos
    Buy
    Buy Divi's Laboratories, target Rs 1,660: Kunal Bothra| Recos
    Buy
    Buy Divi's Laboratories, target Rs 1,680: Kunal Bothra| Recos
    Buy
    Buy Divi's Laboratories, target Rs 1,756: Emkay Global| Recos
    Buy
    Divi's Laboratories Ltd.News Clarification| Announcement
    Divi's Laboratories Ltd.Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)| Announcement
    Divi's Laboratories Ltd.Shareholder Meeting / Postal Ballot-Scrutinizers Report| Announcement
    Divi's Laboratories Ltd.Shareholder Meeting / Postal Ballot-Outcome of AGM| Announcement
    Divi's Laboratories Ltd.ChairmanS Speech And Managing DirectorS Speech Delivered At The 30Th Annual General Meeting Of The Company| Announcement
    Divi's Laboratories Ltd.Announcement under Regulation 30 (LODR)-Newspaper Publication| Announcement
    Divi's Laboratories Ltd.Notice Of 30Th Annual General Meeting| Announcement
    Divi's Laboratories Ltd.Reg. 34 (1) Annual Report| Announcement
    Divi's Laboratories Ltd.Reg. 34 (1) Annual Report| Announcement
    Divi's Laboratories Ltd.Announcement under Regulation 30 (LODR)-Newspaper Publication| Announcement
    Divi's Laboratories Ltd.Book Closure For 30Th Annual General Meeting Of The Company To Be Held On 14 September, 2020| Announcement
    Divi's Laboratories Ltd.30Th Annual General Meeting Of The Company To Be Held On 14 September, 2020| Announcement
    Divi's Laboratories Ltd.Announcement under Regulation 30 (LODR)-Newspaper Publication| Announcement
    Divi's Laboratories Ltd.Outcome Of Board Meeting And Un-Audited Financial Results For The Quarter Ended 30 June, 2020| Announcement
    Divi's Laboratories Ltd.Schedule Of Earnings Conference Call Q1 FY21 To Be Held On 08 August, 2020| Announcement
    Divi's Laboratories Ltd.Board Meeting Intimation for Consideration And Approval Of The Standalone And Consolidated Unaudited Financial Results F...| Announcement
    Divi's Laboratories Ltd.Intimation Of Chief Financial Officer Going On Leave| Announcement
    Divi's Laboratories Ltd.Shareholding for the Period Ended June 30, 2020| Announcement
    Divi's Laboratories Ltd.Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018| Announcement
    Divi's Laboratories Ltd.Statement Of Investor Complaints For The Quarter Ended June 2020| Announcement

    Divi's Laboratories Ltd. Share Price Updates

    Divi's Laboratories Ltd. share price up by 1.33% from its previous close of Rs 3020.45. Divi's Laboratories Ltd. stock last traded price is 3060.75
    Divi's Laboratories Ltd. Share Price
    Value
    Today/Current/Last
    3060.75
    Previous Day
    3020.45
    What's your view on Divi's Laboratories for the week?
    Bearish
    Bullish
    View community Outlook >>

    Be the first one to post on Divi's Laboratories Ltd.

    Divi's Laboratories Ltd.
    Quarterly Results

    Figures in Rs. Cr
    Jun 2020 
    % Chg (Quarterly)
    % Chg (Yearly)
    Peer Range
    Trend
    Last 12 Quarters Trend
    Sales
    1,730.47
    24.52
    48.81
    0.00
    7585.25
    Other Operating Income
    0.00
    0.00
    0.00
    -0.72
    118.06
    Operating Profit
    700.08
    57.52
    80.83
    -14.20
    2526.83
    Other Income
    17.33
    -77.41
    -42.84
    0.00
    153.79
    EBITDA
    717.41
    37.65
    71.85
    -14.20
    2526.83
    Interest
    0.23
    -47.73
    -28.13
    0.00
    102.00
    Depreciation
    56.20
    12.90
    28.22
    0.00
    495.92
    Tax
    168.92
    104.18
    67.46
    -110.66
    305.90
    Net Profit
    492.06
    26.74
    80.61
    -1655.60
    780.58
    EPS (₹)
    18.54
    26.81
    80.70
    -10.81
    68.30

    Divi's Laboratories Ltd Share Price

    Vs Peers
    Companies
    LTP
    Intraday
    1W %
    1M %
    1 QTR %
    1 YR %
    3 YR %
    5 Yr %
    Trend -
    D|M|Y
    3060.75
    1.33
    -8.48
    -5.70
    31.34
    87.38
    221.27
    172.94
    998.90
    1.97
    -8.01
    2.75
    6.81
    36.57
    0.73
    -49.81
    385.50
    2.44
    -5.91
    -0.70
    6.10
    54.76
    -20.01
    -5.46
    2802.35
    0.50
    -2.52
    0.13
    19.21
    47.04
    51.84
    0.00
    772.10
    3.81
    -6.76
    -11.45
    -2.25
    28.21
    10.17
    4.06
    770.10
    5.00
    -4.48
    2.99
    21.29
    77.20
    33.42
    19.75
    5112.20
    1.69
    -4.15
    15.46
    27.59
    84.33
    111.49
    28.76
    955.10
    2.67
    -0.88
    -4.23
    4.47
    84.61
    97.07
    41.33
    2719.25
    2.60
    -5.46
    -3.03
    8.77
    59.66
    121.06
    94.14
    2067.25
    -0.14
    -4.61
    1.22
    24.02
    122.14
    316.91
    168.16
    428.00
    4.84
    -5.73
    10.48
    5.86
    96.11
    149.93
    487.67
    Top Loser for the period amongst the peers
    Top Gainer for the period amongst the peers

    Divi's Laboratories Ltd Risk Return Comparison

    with peersNew

    Divi's Laboratories Ltd
    Financial Comparison

    with peers
    Management Efficiency
    Divi's Laboratories Ltd 
    peer Average
    Peer Range
    Trend
    Return on Equity (%)
    18.83
    7.15
    -97.73
    37.52
    Return on Assets (%)
    18.20
    5.06
    -34.68
    37.98
    Return on capital Employed (%)
    12.74
    9.13
    -13.51
    32.77
    Fixed Assets Turnover (x)
    0.75
    0.41
    -36.70
    3.05
    Profitability and Growth
    Gross Profit Margin (%)
    30.32
    8.10
    -100.49
    43.32
    Operating Profit Margin(%)
    33.77
    14.28
    -46.07
    46.18
    Net Profit margin (%)
    25.51
    -0.11
    -357.87
    38.01
    Financial Strength
    Liquidity
    Quick Ratio (x)
    1.67
    1.98
    0.08
    37.52
    Current Ratio (x)
    3.24
    2.76
    0.21
    37.52
    Cash ratio (x)
    0.10
    0.24
    0.00
    2.43
    Solvency
    Debt Equity Ratio (x)
    0.00
    0.23
    0.00
    3.08
    Coverage Ratios
    Cash flows to long term debt (x)
    0.02
    2.79
    0.00
    24.88
    Better performer than its peers on this ratioAverage performer than its peers on this ratioUnderperformer than its peers on this ratio

    Divi's Laboratories Ltd Share Holding as on 30-06-2020

    CategoryNo. of sharesPercentage
    Promoters137,954,36051.97
    ForeignInstitutions48,237,78618.17
    NBanksMutualFunds41,332,66015.57
    Others11,897,5044.48
    GeneralPublic22,793,5628.59
    FinancialInstitutions3,252,7081.23

    MF Ownership Of Divi's Laboratories Ltd. Shares

    Fund Name
    Category
    No. of shares
    % Change in Shares (MOM basis)
    % of AUM
    Amount Invested (in ₹ Cr)
    SBI Equity Hybrid Direct-G
    Portfolio as on 31-08-2020
    Hybrid: Aggressive Hybrid
    4171563
    -16.57%
    4.07%
    1302.70
    SBI Bluechip Direct-G
    Portfolio as on 31-08-2020
    Equity: Large Cap
    3611156
    0.00%
    4.99%
    1127.69
    Axis Long Term Equity Direct-G
    Portfolio as on 31-08-2020
    Equity: ELSS
    3377574
    0.00%
    4.82%
    1054.75
    HDFC Mid-Cap Opportunities Direct-G
    Portfolio as on 31-08-2020
    Equity: Mid Cap
    2138903
    0.00%
    3.02%
    667.94
    Axis Bluechip Direct-G
    Portfolio as on 31-08-2020
    Equity: Large Cap
    1585000
    10.84%
    2.95%
    494.96

    Liquid, Ultra Short Term funds and FMPs are not taken into account.

    More Schemes »

    About Divi's Laboratories Ltd.

    Divi's Laboratories Ltd., incorporated in the year 1990, is a Large Cap company (having a market cap of Rs 81253.30 Crore) operating in Pharmaceuticals sector.

    Divi's Laboratories Ltd. key Products/Revenue Segments include Active Pharma Ingredients which contributed Rs 5198.31 Crore to Sales Value (97.88 % of Total Sales), Export Incentives which contributed Rs 86.48 Crore to Sales Value (1.62 % of Total Sales), Scrap which contributed Rs 16.77 Crore to Sales Value (0.31 % of Total Sales) and Contract Fees which contributed Rs 9.01 Crore to Sales Value (0.16 % of Total Sales)for the year ending 31-Mar-2020.

    For the quarter ended 30-06-2020, the company has reported a Consolidated sales of Rs 1730.47 Crore, up 24.52 % from last quarter Sales of Rs 1389.71 Crore and up 48.81 % from last year same quarter Sales of Rs 1162.88 Crore Company has reported net profit after tax of Rs 492.06 Crore in latest quarter.

    The company’s top management includes Dr.G Suresh Kumar, Ms.Nilima Motaparti, Mr.R Ranga Rao, Mr.N V Ramana, Mr.Madhusudana Rao Divi, Mr.Kiran S Divi, Mr.K V K Seshavataram, Mr.K V Chowdary, Dr.S Ganapaty, Dr.Ramesh B V Nimmagadda, Dr.Murali K Divi, Prof.Sunaina Singh. Company has Price Waterhouse Chartered Accountants LLP as its auditors As on 30-06-2020, the company has a total of 265,468,580 shares outstanding.

    Close X
    WatchlistPortfolio

    Current Price>: 2389.88

    Set Alert

    Loading
    Please wait...

    Date Sources:Live BSE and NSE Quotes Service: TickerPlant | Corporate Data, F&O Data & Historical price volume data: Dion Global Solutions Ltd.
    BSE Quotes and Sensex are real-time and licensed from the Bombay Stock Exchange. NSE Quotes and Nifty are also real time and licenced from National Stock Exchange. All times stamps are reflecting IST (Indian Standard Time).
    By using this site, you agree to the Terms of Service and Privacy Policy.

    The Economic Times

    Loadingdata
    More on:
    Prices| Financials | Company Info | Reports | News | Competitors